VOGT-KOYANAGI-HARADA DISEASE

VOGT-KOYANAGI-HARADA DISEASE was reported 220 times

These drug classes are most commonly taken by patients reporting VOGT-KOYANAGI-HARADA DISEASE:

# Drug Count
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 84
1 Corticosteroid [EPC] 42
2 CTLA-4-directed Blocking Antibody [EPC] 35
3 Tumor Necrosis Factor Blocker [EPC] 32
4 Folate Analog Metabolic Inhibitor [EPC] 16
5 Platinum-based Drug [EPC] 16
6 Nonsteroidal Anti-inflammatory Drug [EPC] 15
7 Kinase Inhibitor [EPC] 13
8 Rifamycin Antibacterial [EPC] 11
9 Microtubule Inhibitor [EPC] 8
10 Calcineurin Inhibitor Immunosuppressant [EPC] 7
11 Interleukin-6 Receptor Antagonist [EPC] 6
12 Nucleoside Metabolic Inhibitor [EPC] 6
13 Prostaglandin Analog [EPC] 6
14 HER2/neu Receptor Antagonist [EPC] 5
15 CD20-directed Cytolytic Antibody [EPC] 4
16 Interleukin-4 Receptor alpha Antagonist [EPC] 4
17 Janus Kinase Inhibitor [EPC] 4
18 Non-Standardized Food Allergenic Extract [EPC] 4
19 Non-Standardized Plant Allergenic Extract [EPC] 4
20 Photoactivated Radical Generator [EPC] 4
21 Psoralen [EPC] 4
22 Vitamin B12 [EPC] 4
23 Vitamin C [EPC] 4
24 Vitamin D [EPC] 4
25 mTOR Inhibitor Immunosuppressant [EPC] 4
26 Carbonic Anhydrase Inhibitor [EPC] 3
27 Nucleoside Analog Antiviral [EPC] 3
28 Purine Antimetabolite [EPC] 3
29 Vascular Endothelial Growth Factor Inhibitor [EPC] 3
30 Aldosterone Antagonist [EPC] 2
31 Alkylating Drug [EPC] 2
32 CD52-directed Cytolytic Antibody [EPC] 2
33 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
34 Endothelin Receptor Antagonist [EPC] 2
35 GLP-1 Receptor Agonist [EPC] 2
36 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 2
37 HMG-CoA Reductase Inhibitor [EPC] 2
38 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2
39 Histamine-2 Receptor Antagonist [EPC] 2
40 Loop Diuretic [EPC] 2
41 Prostacyclin Receptor Agonist [EPC] 2
42 Proton Pump Inhibitor [EPC] 2
43 Soluble Guanylate Cyclase Stimulator [EPC] 2
44 Sulfonamide Antimicrobial [EPC] 2
45 Xanthine Oxidase Inhibitor [EPC] 2
46 alpha-Adrenergic Blocker [EPC] 2
47 beta-Adrenergic Blocker [EPC] 2
48 Androgen Receptor Inhibitor [EPC] 1
49 Antifibrinolytic Agent [EPC] 1
50 Antimetabolite Immunosuppressant [EPC] 1
51 Azole Antifungal [EPC] 1
52 Benzodiazepine [EPC] 1
53 CD30-directed Immunoconjugate [EPC] 1
54 Calcium [EPC] 1
55 Complement Inhibitor [EPC] 1
56 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
57 Epidermal Growth Factor Receptor Antagonist [EPC] 1
58 Glinide [EPC] 1
59 Hepatitis C Virus NS5A Inhibitor [EPC] 1
60 Integrin Receptor Antagonist [EPC] 1
61 Interferon beta [EPC] 1
62 Interleukin-1 Receptor Antagonist [EPC] 1
63 Interleukin-12 Antagonist [EPC] 1
64 Interleukin-17A Antagonist [EPC] 1
65 Interleukin-23 Antagonist [EPC] 1
66 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1
67 Leukotriene Receptor Antagonist [EPC] 1
68 Lipid-based Polyene Antifungal [EPC] 1
69 Orexin Receptor Antagonist [EPC] 1
70 Phosphodiesterase 4 Inhibitor [EPC] 1
71 Platelet Aggregation Inhibitor [EPC] 1
72 Polyene Antifungal [EPC] 1
73 Programmed Death Ligand-1 Blocker [EPC] 1
74 Quinolone Antimicrobial [EPC] 1
75 RANK Ligand Inhibitor [EPC] 1
76 Selective T Cell Costimulation Modulator [EPC] 1
77 Serotonin-3 Receptor Antagonist [EPC] 1
78 Thymic Stromal Lymphopoietin Blocker [EPC] 1
79 Topoisomerase Inhibitor [EPC] 1
80 Vitamin K [EPC] 1
81 Warfarin Reversal Agent [EPC] 1